Alteration of cell-mediated immunity to Listeria monocytogenes in protein-malnourished mice treated with thymosin fraction V
- PMID: 6981605
- PMCID: PMC347575
- DOI: 10.1128/iai.37.2.601-608.1982
Alteration of cell-mediated immunity to Listeria monocytogenes in protein-malnourished mice treated with thymosin fraction V
Abstract
Cell-mediated immune reactivity, measured by lymphocyte responsiveness to phytohemagglutinin, was higher in both young or aged mice fed a 4% casein diet compared with age-matched controls. Treatment in vivo with bovine thymosin fraction V decreased the responsiveness to phytohemagglutinin of lymphocytes from mice fed either the control or moderately protein-deficient diets when compared with mice treated in vivo with saline. Resistance against Listeria monocytogenes, known to be a cell-mediated immune function, was impaired in young and aged mice which were fed the low-protein diet. Treatment with thymosin was able to significantly improve the cell-mediated immune resistance to L. monocytogenes of moderately protein-malnourished mice. Thymosin treatment impaired the resistance to L. monocytogenes of young or aged mice fed the control diet. The splenic natural killer cell cytotoxicity of protein-malnourished mice was impaired compared with that of mice fed the control diet. Treatment with thymosin did not restore the natural killer cell cytotoxic activity in protein-malnourished mice, but did enhance that activity in control mice.
Similar articles
-
Thymosin treatment: serum corticosterone and lymphocyte mitogenesis in moderately and severely protein-malnourished mice.J Nutr. 1983 Mar;113(3):483-93. doi: 10.1093/jn/113.3.483. J Nutr. 1983. PMID: 6600784
-
Resistance to L1210 mouse leukemia cells in moderately protein-malnourished BALB/c mice treated in vivo with thymosin fraction V.Cancer Res. 1982 Jun;42(6):2139-45. Cancer Res. 1982. PMID: 6804089
-
Thymosin fraction 5: effects on T cell functions in mice immunosuppressed by severe dietary protein deficiency.Int J Immunopharmacol. 1986;8(6):545-52. doi: 10.1016/0192-0561(86)90024-x. Int J Immunopharmacol. 1986. PMID: 3098692
-
Thymosin: basic properties and clinical potential in the treatment of patients with immunodeficiency diseases and cancer.Antibiot Chemother (1971). 1978;24:47-59. doi: 10.1159/000401500. Antibiot Chemother (1971). 1978. PMID: 350140 Review. No abstract available.
-
[Results and prospects of using thymosin for the purpose of regulating the immune system in different pathological processes and states].Zh Mikrobiol Epidemiol Immunobiol. 1979 Dec;(12):9-15. Zh Mikrobiol Epidemiol Immunobiol. 1979. PMID: 390944 Review. Russian. No abstract available.
Cited by
-
Resistance and susceptibility to infection in inbred murine strains. III. Effect of thymosin on cellular immune responses of alloxan diabetic mice.Clin Exp Immunol. 1984 Jan;55(1):133-9. Clin Exp Immunol. 1984. PMID: 6420098 Free PMC article.
-
Thymosin alpha 11: a peptide related to thymosin alpha 1 isolated from calf thymosin fraction 5.Proc Natl Acad Sci U S A. 1983 Dec;80(24):7424-7. doi: 10.1073/pnas.80.24.7424. Proc Natl Acad Sci U S A. 1983. PMID: 6369316 Free PMC article.
-
Influences of nutrition on immunity and susceptibility to mouse hepatitis virus type 2.Immunology. 1985 Jul;55(3):539-45. Immunology. 1985. PMID: 2991126 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical